PLEOMORPHIC LIPOSARCOMA

This adverse event was reported 11 times

PLEOMORPHIC LIPOSARCOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ICOSAPENT ETHYL 1 0.0001
1 PAZOPANIB HYDROCHLORIDE 2 0.0001
2 IFOSFAMIDE FOR INJECTION 1 0.0000
3 FINGOLIMOD HCL 1 0.0000
4 DOXORUBICIN 1 0.0000
5 IBUPFROFEN 2 0.0000
6 IBUPROFEN TABLETS USP, 200MG 2 0.0000
7 IBUPROFEN ORAL 2 0.0000
8 IBUPROFEN CAPSULES 200 MG 2 0.0000
9 ATENOLOL 1 0.0000
See all drugs enriched for association with PLEOMORPHIC LIPOSARCOMA

PLEOMORPHIC LIPOSARCOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Alkylating Drug [EPC] 1 0.0000
1 beta-Adrenergic Blocker [EPC] 1 0.0000
2 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
3 Platelet Aggregation Inhibitor [EPC] 1 0.0000
4 Benzodiazepine [EPC] 1 0.0000
5 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with PLEOMORPHIC LIPOSARCOMA